We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Advances in pharmacotherapy for pediatric anxiety disorders.
- Authors
Rynn, Moira; Puliafico, Anthony; Heleniak, Charlotte; Rikhi, Pranav; Ghalib, Kareem; Vidair, Hilary
- Abstract
Pediatric anxiety disorders are prevalent, chronic, and often lead to significant impaired functioning that impacts both short- and long-term outcomes for children and adolescents. Treatment options include pharmacotherapy and psychosocial interventions. This presentation will review treatment advances specifically for pharmacotherapy. Current research supports serotonin reuptake inhibitors as the medication class to be the first-line treatment option for pediatric anxiety disorders. Available evidence for the efficacy of other classes of medications will be reviewed, along with the available approaches to manage partial responders and nonresponders. The risks and benefits of pharmacotherapy will also be reviewed. In addition, recent research has shown the potential promise of novel agents that act upon other neural systems implicated in the development of pediatric anxiety disorders. Novel compounds that affect the glutamate system will be discussed. Depression and Anxiety, 2011. © 2011 Wiley-Liss, Inc.
- Subjects
ANXIETY disorders; ANXIETY in children; DRUG therapy; GENERALIZED anxiety disorder; POST-traumatic stress disorder in children; SOCIAL phobia in children; CHILD psychopathology
- Publication
Depression & Anxiety (1091-4269), 2011, Vol 28, Issue 1, p76
- ISSN
1091-4269
- Publication type
Article
- DOI
10.1002/da.20769